{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:23:16Z","timestamp":1773325396478,"version":"3.50.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[2013,4,10]],"date-time":"2013-04-10T00:00:00Z","timestamp":1365552000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s12026-013-8408-9","type":"journal-article","created":{"date-parts":[[2013,4,9]],"date-time":"2013-04-09T07:29:07Z","timestamp":1365492547000},"page":"362-370","source":"Crossref","is-referenced-by-count":45,"title":["Rituximab in refractory idiopathic inflammatory myopathies and antisynthetase syndrome: personal experience and review of the literature"],"prefix":"10.1007","volume":"56","author":[{"given":"Linda","family":"Nalotto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Iaccarino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margherita","family":"Zen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariele","family":"Gatto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Borella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Domenighetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Punzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Doria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,10]]},"reference":[{"key":"8408_CR1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","volume":"362","author":"MC Dalakas","year":"2003","unstructured":"Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003;362:971\u201382.","journal-title":"Lancet"},{"key":"8408_CR2","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","volume":"325","author":"MC Dalakas","year":"1991","unstructured":"Dalakas MC. Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med. 1991;325:1487\u201398.","journal-title":"N Engl J Med"},{"key":"8408_CR3","first-page":"1335","volume-title":"Myology","author":"AG Engel","year":"1994","unstructured":"Engel AG, Hohlfeld R, Banker BQ. The polymyositis and dermatomyositis syndromes. In: Engel AG, Franzini-Armstrong C, editors. Myology. 2nd ed. New York: McGraw-Hill; 1994. p. 1335\u201383.","edition":"2"},{"key":"8408_CR4","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0889-857X(02)00021-2","volume":"28","author":"FL Mastaglia","year":"2002","unstructured":"Mastaglia FL, Phillips BA. Idiopathic inflammatory myopathies: epidemiology, classification and diagnostic criteria. Rheum Dis Clin N Am. 2002;28:723\u201341.","journal-title":"Rheum Dis Clin N Am"},{"key":"8408_CR5","first-page":"636","volume-title":"Disorders of voluntary muscle","author":"MC Dalakas","year":"2001","unstructured":"Dalakas MC, Karpati G. The inflammatory myopathies. In: Karpati G, Hilton-Jones D, Griggs RC, editors. Disorders of voluntary muscle. 7th ed. Cambridge: Cambridge University Press; 2001. p. 636\u201359.","edition":"7"},{"key":"8408_CR6","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/00019052-200110000-00007","volume":"14","author":"D Hilton-Jones","year":"2001","unstructured":"Hilton-Jones D. Inflammatory myopathies. Curr Opin Neurol. 2001;14:591\u20136.","journal-title":"Curr Opin Neurol"},{"key":"8408_CR7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/08916930600622132","volume":"39","author":"C Briani","year":"2006","unstructured":"Briani C, Doria A, Sarzi-Puttini P, Dalakas MC. Update in idiopathic inflammatory myopathies. Autoimmunity. 2006;39:161\u201370.","journal-title":"Autoimmunity"},{"key":"8408_CR8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.autrev.2009.12.005","volume":"9","author":"S Zampieri","year":"2010","unstructured":"Zampieri S, Valente M, Adami N, Biral D, Ghirardello A, Rampudda ME, et al. Polymyositis, dermatomyositis and malignancy: a further intriguing link. Autoimmun Rev. 2010;9:449\u201353.","journal-title":"Autoimmun Rev"},{"key":"8408_CR9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/ar2963","volume":"12","author":"M Vittadello","year":"2010","unstructured":"Vittadello M, Doria A, Tarricone E, Ghirardello A, Gorza L. Myofiber stress-response in myositis: parallel investigations on patients and experimental animal models of muscle regeneration and systemic inflammation. Arthritis Res Ther. 2010;12:52.","journal-title":"Arthritis Res Ther"},{"key":"8408_CR10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12016-010-8238-7","volume":"41","author":"A Ghirardello","year":"2011","unstructured":"Ghirardello A, Zampieri S, Tarricone E, Iaccarino L, Gorza L, Doria A. Cutting edge in polymyositis. Clin Rev Allerg Immunol. 2011;41:179\u201389.","journal-title":"Clin Rev Allerg Immunol"},{"key":"8408_CR11","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1136\/ard.2006.052191","volume":"65","author":"GJD Hengstman","year":"2006","unstructured":"Hengstman GJD, Ter Laak HJ, VreeEgberts WTM, Lundberg IE, Moutsopoulos HM, Vencovsky J, et al. Anti-signal recognition particle autoantibodies: marker of necrotizing myopathy. Ann Rheum Dis. 2006;65:1635\u20138.","journal-title":"Ann Rheum Dis"},{"key":"8408_CR12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/08916930600622348","volume":"39","author":"S Zampieri","year":"2006","unstructured":"Zampieri S, Ghirardello A, Iaccarino L, Briani C, Sarzi-Puttini P, Azteni F, et al. Polymyositis-dermatomyositis and infections. Autoimmunity. 2006;39:161\u201370.","journal-title":"Autoimmunity"},{"key":"8408_CR13","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s00393-006-0059-y","volume":"65","author":"A Doria","year":"2006","unstructured":"Doria A, Iaccarino L, Ghirardello A, Arienti S, Zampieri S, Rampudda ME, et al. Rare autommune rheumatic illness during pregnancy. Systemic sclerosis, polymyositis\/dermatomyositis and vasculitis. Z Rheumatol. 2006;65:200\u20138.","journal-title":"Z Rheumatol."},{"key":"8408_CR14","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1191\/0961203304lu1098oa","volume":"13","author":"A Doria","year":"2004","unstructured":"Doria A, Iaccarino L, Ghirardello A, Briani C, Zampieri S, Tarricone E, et al. Pregnancy in rare autoimmune rheumatic diseases: UCTD, MCTD, myositis, systemic vasculitis and Beh\u00e7et disease. Lupus. 2004;13:690\u20135.","journal-title":"Lupus"},{"key":"8408_CR15","first-page":"410","volume":"69","author":"AE Hak","year":"2011","unstructured":"Hak AE, de Paepe B, de Bleecker JL, Tak PP, de Visser M. Dermatomyositis and polymyositis: new treatment targets on the horizon. Neth J Med. 2011;69:410\u201321.","journal-title":"Neth J Med"},{"key":"8408_CR16","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1093\/rheumatology\/keq281","volume":"49","author":"A Ghirardello","year":"2010","unstructured":"Ghirardello A, Rampudda M, Ekholm L, Bassi N, Tarricone E, Zampieri S, et al. Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay. Rheumatology (Oxford). 2010;49:2370\u20134.","journal-title":"Rheumatology (Oxford)"},{"key":"8408_CR17","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.autrev.2009.02.012","volume":"8","author":"A Ghirardello","year":"2009","unstructured":"Ghirardello A, Bendo R, Rampudda ME, Bassi N, Zampieri S, Doria A. Commercial blot assays in the diagnosis of systemic rheumatic diseases. Autoimmun Rev. 2009;8:645\u20139.","journal-title":"Autoimmun Rev"},{"key":"8408_CR18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1179\/174313208X281154","volume":"30","author":"S Zampieri","year":"2008","unstructured":"Zampieri S, Biral D, Adami N, Ghirardello A, Rampudda ME, Tonello M, et al. Expression of myositis specific autoantigens during post-natal myogenesis. Neurol Res. 2008;30:145\u20138.","journal-title":"Neurol Res"},{"key":"8408_CR19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/08916930600622645","volume":"39","author":"A Ghirardello","year":"2006","unstructured":"Ghirardello A, Zampieri S, Tarricone E, Iaccarino L, Bendo R, Briani C, et al. Clinical implications of autoantibody screening in patients with autoimmune myositis. Autoimmunity. 2006;39:217\u201321.","journal-title":"Autoimmunity"},{"key":"8408_CR20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/08916930400022681","volume":"38","author":"A Ghirardello","year":"2005","unstructured":"Ghirardello A, Zampieri S, Iaccarino L, Tarricone E, Bendo R, Gambari PF, et al. Anti-Mi-2 antibodies. Autoimmunity. 2005;38:79\u201383.","journal-title":"Autoimmunity"},{"key":"8408_CR21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/08916930400022640","volume":"38","author":"S Zampieri","year":"2005","unstructured":"Zampieri S, Ghirardello A, Iaccarino L, Tarricone E, Gambari PF, Doria A. Anti-Jo-1 antibodies. Autoimmunity. 2005;38:73\u20138.","journal-title":"Autoimmunity"},{"key":"8408_CR22","first-page":"22","volume":"57","author":"A Ghirardello","year":"2005","unstructured":"Ghirardello A, Zampieri S, Iaccarino L, Tarricone E, Tonello M, Bendo R, et al. Myositis specific and myositis associated autoantibodies in idiopathic inflammatory myopathies: a serologic study of 46 patients. Reumatismo. 2005;57:22\u20138.","journal-title":"Reumatismo"},{"key":"8408_CR23","first-page":"1393","volume":"29","author":"F Franceschini","year":"2002","unstructured":"Franceschini F, Cavazzana I, Generali D, Quinzanini M, Viardi L, Ghirardello A, et al. Anti-Ku autoantibodies in connective tissue diseases: clinical and serological evaluation of 14 patients. J Rheumatol. 2002;29:1393\u20137.","journal-title":"J Rheumatol"},{"key":"8408_CR24","doi-asserted-by":"crossref","unstructured":"Iaccarino L, Gatto M, Bettio S, Caso F, Rampudda M, Zen M, et al. Overlap connective tissue disease syndromes. Autoimmun Rev. 2012. doi: 10.1016\/j.autrev.2012.06.004 .","DOI":"10.1016\/j.autrev.2012.06.004"},{"key":"8408_CR25","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s00296-009-0859-x","volume":"29","author":"E Vandenbroucke","year":"2009","unstructured":"Vandenbroucke E, Grutters JC, Altenburg J, Boersma WG, ter Borg EJ, van den Bosch JMM. Rituximab in life threatening antisynthetase syndrome. Rheumatol Int. 2009;29:1499\u2013502.","journal-title":"Rheumatol Int"},{"key":"8408_CR26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.autrev.2011.06.007","volume":"11","author":"I Marie","year":"2011","unstructured":"Marie I, Mouthon L. Therapy of polymyositis and dermatomyositis. Autoimmun Rev. 2011;11:6\u201313.","journal-title":"Autoimmun Rev"},{"key":"8408_CR27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrrheum.2010.2","volume":"6","author":"MC Dalakas","year":"2010","unstructured":"Dalakas MC. Immunotherapy of myositis: issues, concerns and future prospects. Nat Rev Rheumatol. 2010;6:129\u201337.","journal-title":"Nat Rev Rheumatol"},{"key":"8408_CR28","first-page":"1864","volume":"34","author":"CC Mok","year":"2007","unstructured":"Mok CC, Ho LY, To CH. Rituximab for refractory polymyositis: an open-label prospective study. J Rheumatol. 2007;34:1864\u20138.","journal-title":"J Rheumatol"},{"key":"8408_CR29","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.rmed.2012.01.001","volume":"106","author":"I Marie","year":"2012","unstructured":"Marie I, Dominique S, Janvresse A, Levesque H, Menard JF. Rituximab therapy for refractory interstitial lung disease related to antisyntetase syndrome. Respir Med. 2012;106:581\u20137.","journal-title":"Respir Med"},{"key":"8408_CR30","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/art.20849","volume":"52","author":"TD Levine","year":"2005","unstructured":"Levine TD. Rituximab in the treatment of dermatomyositis: an open-label pilot study. Arthritis Rheum. 2005;52:601\u20137.","journal-title":"Arthritis Rheum"},{"key":"8408_CR31","first-page":"1021","volume":"33","author":"EH Noss","year":"2006","unstructured":"Noss EH, Hausner-Sypek DL, Weinblatt ME. Rituximab as therapy for refractory polymyositis and dermatomyositis. J Rheumatol. 2006;33:1021\u20136.","journal-title":"J Rheumatol"},{"key":"8408_CR32","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/ard.2005.045898","volume":"65","author":"L Brulhart","year":"2006","unstructured":"Brulhart L, Waldburger JM, Gabay C. Rituximab in the treatment of antisynthetase syndrome. Ann Rheum Dis. 2006;65:974\u20135.","journal-title":"Ann Rheum Dis"},{"key":"8408_CR33","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jaad.2006.05.068","volume":"56","author":"HV Dinh","year":"2007","unstructured":"Dinh HV, McCormack C, Hall S, Prince HM. Rituximab for the treatment of the skin manifestations of dermatomyositis: a report of 3 cases. J Am Acad Dermatol. 2007;56:148\u201353.","journal-title":"J Am Acad Dermatol"},{"key":"8408_CR34","first-page":"6","volume":"35","author":"E Feist","year":"2008","unstructured":"Feist E, Dorner T, Sorensen H, Burdmester GR. Long-lasting remission after treatment with rituximab for autoimmune myositis. J Rheumatol. 2008;35:6.","journal-title":"J Rheumatol"},{"key":"8408_CR35","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/rheumatology\/kep147","volume":"48","author":"F Frikha","year":"2009","unstructured":"Frikha F, Rigolet A, Behin A, Fautrel B, Herson S, Benveniste O. Efficacy of rituximab in refractory and relapsing myositis with anti-Jo1 antibodies: a report of two cases. Rheumatology. 2009;48:1066\u2013180.","journal-title":"Rheumatology"},{"key":"8408_CR36","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00296-009-1000-x","volume":"30","author":"S S\u00e0nchez-Ram\u00f2n","year":"2010","unstructured":"S\u00e0nchez-Ram\u00f2n S, Ravell JC, de la Torre I, Montoro M, Rodr\u00ecguez-Mahou M, Carre\u00f1o-P\u00e8rez L, et al. Long-term remission of severe refractory dermatopolymyositis with a weekly-scheme of immunoglobulin followed by rituximab therapy. Rheumatol Int. 2010;30:817\u20139.","journal-title":"Rheumatol Int"},{"key":"8408_CR37","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/rheumatology\/kep157","volume":"48","author":"M Sem","year":"2009","unstructured":"Sem M, Molberg Z, Lund MB, Grand MT. Rituximab treatment of the anti-syntetase syndrome\u2014a retrospective case series. Rheumatology. 2009;48:968\u201371.","journal-title":"Rheumatology"},{"key":"8408_CR38","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/acr.20219","volume":"62","author":"R Valiyil","year":"2010","unstructured":"Valiyil R, Casciola-Rosen L, Hong G, Mammen A, Christopher-Stine L. Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series. Arthritis Care Res. 2010;62:1328\u201334.","journal-title":"Arthritis Care Res"},{"key":"8408_CR39","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/rheumatology\/ker305","volume":"50","author":"M Couderc","year":"2011","unstructured":"Couderc M, Gottenberg JE, Mariette X, Hachulla E, Sibilia J, Fain O, et al. Efficacy and safety of rituximab in the treatment of refractory inflammatory myopathies in adults: results from the AIR registry. Rheumatology. 2011;50:2283\u20139.","journal-title":"Rheumatology"},{"key":"8408_CR40","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/01.rhu.0000182155.08982.60","volume":"11","author":"N Chiappetta","year":"2005","unstructured":"Chiappetta N, Steirer J, Gruber B. Rituximab in the treatment of refractory polymyositis. J Clin Rheumatol. 2005;11:264\u20136.","journal-title":"J Clin Rheumatol"},{"key":"8408_CR41","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jbspin.2007.05.011","volume":"75","author":"Z Touma","year":"2008","unstructured":"Touma Z, Arayssi T, Kibbi L, Masri AF. Successful treatment of cardiac involvement in dermatomyositis with rituximab. Jt Bone Spine. 2008;75:334\u20137.","journal-title":"Jt Bone Spine"},{"key":"8408_CR42","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4067\/S0034-98872009000100013","volume":"137","author":"VJ Y\u00e1\u00f1ez","year":"2009","unstructured":"Y\u00e1\u00f1ez VJ, Cisternas MM, Sald\u00edas HV, Sald\u00edas PF. Refractory dermatomyositis associated with chronic organizing pneumonia treated with rituximab. Report of one case. Rev M\u00e9d Chile. 2009;137:88\u201393.","journal-title":"Rev M\u00e9d Chile"},{"key":"8408_CR43","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/rheumatology\/kep027","volume":"48","author":"BR Whelan","year":"2009","unstructured":"Whelan BR, Isenberg DA. Poor response of anti-SRP-positive idiopathic immune myositis to B-cell depletion. Rheumatology. 2009;48:594\u20135.","journal-title":"Rheumatology"},{"key":"8408_CR44","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4103\/0028-3886.79163","volume":"59","author":"R Jois","year":"2011","unstructured":"Jois R, Vasudevan N, Srinivasan P, Mehta R. Resistant dermatomyositis complicated by tubercular myositis and successfully treated with rituximab. Neurol India. 2011;59:306\u20137.","journal-title":"Neurol India"},{"key":"8408_CR45","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jbspin.2011.05.021","volume":"79","author":"TA Gheita","year":"2012","unstructured":"Gheita TA, Gheita HA, Kenawy SA. Rituximab restored the muscle power and rescued from a refractory fatal respiratory failure in a patient with elderly-onset polymyositis. Jt Bone Spine. 2012;79:94\u2013102.","journal-title":"Jt Bone Spine"},{"key":"8408_CR46","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1002\/art.22856","volume":"56","author":"MA Cooper","year":"2007","unstructured":"Cooper MA, Willingham DL, Brown DE, French AR, Shih FF, White AJ. Rituximab for the treatment of juvenile dermatomyositis. A report of four pediatric patients. Arthritis Rheum. 2007;56:3107\u201311.","journal-title":"Arthritis Rheum"},{"key":"8408_CR47","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/RHU.0b013e3181bb8e70","volume":"15","author":"S Majmudar","year":"2009","unstructured":"Majmudar S, Hall HA, Zimmermann B. Treatment of adult inflammatory myositis with rituximab: an emerging therapy for refractory patients. J Clin Rheumatol. 2009;15:338\u201340.","journal-title":"J Clin Rheumatol"},{"key":"8408_CR48","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/rheumatology\/ker088","volume":"50","author":"EA Mahler","year":"2011","unstructured":"Mahler EA, Blom M, Voermans NC, van Engelen GM, van Riel PL, Vonk MC. Rituximab treatment in patients with refractory inflammatory myopathies. Rheumatology. 2011;50:2206\u201313.","journal-title":"Rheumatology"},{"key":"8408_CR49","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.medcli.2009.12.022","volume":"135","author":"FJ Garc\u00eda Hern\u00e1ndez","year":"2010","unstructured":"Garc\u00eda Hern\u00e1ndez FJ, Chinchilla Palomares E, Castillo Palma MJ, Gonz\u00e1lez Pulido C, Oca\u00f1a Medina C, S\u00e0nchez Rom\u00e0n J. Evaluation of the effectiveness of treatment with rituximab associated to cyclophosphamide in patients with resistant idiopathic inflammatory myopathy. Med Clin. 2010;135:256\u20139.","journal-title":"Med Clin"},{"key":"8408_CR50","first-page":"1369","volume":"32","author":"O Lambotte","year":"2005","unstructured":"Lambotte O, Kotb R, Maigne G, Blanc FX, Goujard C, Delfraissy JF. Efficacy of rituximab in refractory polymyositis. J Rheumatol. 2005;32:1369\u201370.","journal-title":"J Rheumatol"},{"key":"8408_CR51","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1136\/ard.2004.029694","volume":"64","author":"JE Gottenberg","year":"2005","unstructured":"Gottenberg JE, Guillevin L, Lambotte O, Combe B, Allanore Y, Cantagrel A, et al. Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Ann Rheum Dis. 2005;64:913\u201320.","journal-title":"Ann Rheum Dis"},{"key":"8408_CR52","first-page":"887","volume":"26","author":"SM Sultan","year":"2008","unstructured":"Sultan SM, Ng KP, Edwards JC, Isenberg DA, Cambridge G. Clinical outcome following B cell depletion therapy in eight patients with refractory idiopathic inflammatory myopathy. Clin Exp Rheumatol. 2008;26:887\u201393.","journal-title":"Clin Exp Rheumatol"},{"key":"8408_CR53","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1002\/art.23059","volume":"6","author":"E Keystone","year":"2007","unstructured":"Keystone E, Fleishmann R, Emery P, Furst DE, van Vollenhoven R, Bathon J, et al. Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: an open-label extension analysis. Arthritis Rheum. 2007;6:3896\u2013908.","journal-title":"Arthritis Rheum"},{"key":"8408_CR54","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/BOR.0b013e3282efe261","volume":"19","author":"SA Greenberg","year":"2007","unstructured":"Greenberg SA. A gene expression approach to study perturbed pathways in myositis. Curr Opin Rheumatol. 2007;19:536\u201341.","journal-title":"Curr Opin Rheumatol"},{"key":"8408_CR55","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1084\/jem.20041367","volume":"201","author":"L Casciola-Rosen","year":"2005","unstructured":"Casciola-Rosen L, Nagaraju K, Plotz P, Wang K, Levine S, Gabrielson E, et al. Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. J Exp Med. 2005;201:591\u2013601.","journal-title":"J Exp Med"},{"key":"8408_CR56","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ncprheum0760","volume":"4","author":"TL Suber","year":"2008","unstructured":"Suber TL, Casciola-Rosen L, Rosen A. Mechanisms of disease: autoantigens as clues to the pathogenesis of myositis. Nat Clin Pract Rheum. 2008;4:201\u20139.","journal-title":"Nat Clin Pract Rheum"},{"key":"8408_CR57","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11926-003-0052-2","volume":"5","author":"DP Ascherrman","year":"2003","unstructured":"Ascherrman DP. The role of Jo-1 in the immunopathogenesis of polymyositis: current hypotheses. Curr Rheumatol Rep. 2003;5:425\u201330.","journal-title":"Curr Rheumatol Rep"},{"key":"8408_CR58","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-3083.2012.02728.x","volume":"76","author":"DS Pisetsky","year":"2012","unstructured":"Pisetsky DS. Antinuclear antibodies in rheumatic disease: a proposal for a function-based classification. Scand J Immunol. 2012;76:223\u20138.","journal-title":"Scand J Immunol"},{"key":"8408_CR59","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nrrheum.2011.1","volume":"7","author":"F Hiepe","year":"2011","unstructured":"Hiepe F, D\u00f6rner T, Hauser AE, Hoyer BF, Mei H, Radbruch A. Long-lived autoreactive plasma cells drive persistent autoimmune inflammation. Nat Rev Rheumatol. 2011;7:170\u20138.","journal-title":"Nat Rev Rheumatol"},{"key":"8408_CR60","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/j.seminhematol.2010.01.007","volume":"47","author":"T Meerten van","year":"2010","unstructured":"van Meerten T, Hagenbeek A. CD20-targeted therapy: the next generation of antibodies. Semin Hematol. 2010;47:199.","journal-title":"Semin Hematol"},{"key":"8408_CR61","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/art.21617","volume":"54","author":"MJ Leandro","year":"2006","unstructured":"Leandro MJ, Cambridge G, Ehrenstein MR, Edwards JC. Reconstitution of peripheral blood B cells after depletion with rituximab in patients with RA. Arthritis Rheum. 2006;54:613\u201320.","journal-title":"Arthritis Rheum"},{"key":"8408_CR62","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/rheumatology\/keh443","volume":"44","author":"M Tokunaga","year":"2005","unstructured":"Tokunaga M, Fujii K, Saito K, Nakayamada S, Tsujimura S, Nawata M, Tanaka Y. Down-regulation of CD40 and CD80 on B cells in patients with life-threatening systemic lupus erythematosus after successful treatment with rituximab. Rheumatology. 2005;44:176\u201382.","journal-title":"Rheumatology"},{"key":"8408_CR63","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1186\/ar1954","volume":"8","author":"M Vigna-Perez","year":"2006","unstructured":"Vigna-Perez M, Hern\u00e1ndez-Castro B, Paredes-Saharopulos O, Portales-P\u00e9rez D, Baranda L, Abud-Mendoza C, et al. Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study. Arthritis Res Ther. 2006;8:R83.","journal-title":"Arthritis Res Ther"},{"key":"8408_CR64","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nri2785","volume":"10","author":"S Sakaguchi","year":"2010","unstructured":"Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol. 2010;10:490\u2013500.","journal-title":"Nat Rev Immunol"},{"key":"8408_CR65","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2353\/ajpath.2009.080422","volume":"174","author":"Y Allenbach","year":"2009","unstructured":"Allenbach Y, Solly S, Gregoire S, Dubourg O, Salomon B, Butler-Browne G, et al. Role of regulatory cells in a new mouse model of experimental autoimmune myositis. Am J Pathol. 2009;174:989\u201398.","journal-title":"Am J Pathol"},{"key":"8408_CR66","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1136\/ard.2003.017715","volume":"64","author":"M Aleksza","year":"2005","unstructured":"Aleksza M, Szegedi A, Antal-Szalmas P, Irinyi B, Gergely L, Ponyi A, et al. Altered cytokine expression of peripheral blood lymphocytes in polymyositis and dermatomyositis. Ann Rheum Dis. 2005;64:1485\u20139.","journal-title":"Ann Rheum Dis"},{"key":"8408_CR67","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jneuroim.2010.03.013","volume":"225","author":"A Waschbisch","year":"2010","unstructured":"Waschbisch A, Schwab N, Ruck T, Stenner MP, Wiendl H. FOXP3+ T regulatory cells in idiopathic inflammatory myopathies. J Neuroimmunol. 2010;225:137\u201342.","journal-title":"J Neuroimmunol"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-013-8408-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12026-013-8408-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-013-8408-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T22:06:13Z","timestamp":1559426773000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12026-013-8408-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,10]]},"references-count":67,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["8408"],"URL":"https:\/\/doi.org\/10.1007\/s12026-013-8408-9","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,10]]}}}